|
Volumn 21, Issue 3-4, 2001, Pages 105-110
|
Intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical cancer
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CISPLATIN;
NEDAPLATIN;
ADENOSQUAMOUS CARCINOMA;
ADULT;
ADVANCED CANCER;
AGED;
ALOPECIA;
ARTICLE;
ARTIFICIAL EMBOLISM;
BONE MARROW SUPPRESSION;
CANCER CLASSIFICATION;
CANCER COMBINATION CHEMOTHERAPY;
CANCER STAGING;
CANCER SURVIVAL;
CHEMOTHERAPY INDUCED EMESIS;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CREATININE CLEARANCE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG RESPONSE;
FEMALE;
FOLLOW UP;
HUMAN;
INFORMED CONSENT;
LEUKOPENIA;
NAUSEA;
NEPHROTOXICITY;
NEUROTOXICITY;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PATIENT SELECTION;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PROGNOSIS;
SQUAMOUS CELL CARCINOMA;
SURVIVAL RATE;
THROMBOCYTOPENIA;
UTERINE CERVIX CANCER;
ADENOCARCINOMA;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BALLOON OCCLUSION;
CARCINOMA, ADENOSQUAMOUS;
CARCINOMA, SQUAMOUS CELL;
CISPLATIN;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
INFUSIONS, INTRA-ARTERIAL;
INFUSIONS, INTRAVENOUS;
MIDDLE AGED;
ORGANOPLATINUM COMPOUNDS;
SURVIVAL RATE;
UTERINE CERVICAL NEOPLASMS;
UTERINE NEOPLASMS;
|
EID: 0035560476
PISSN: 02511649
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (16)
|
References (25)
|